Who has invested in CHARM Therapeutics?

New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures are named among the investors backing CHARM Therapeutics.

CHARM Therapeutics Funding: $80M Raised, Series B (2025)

CHARM Therapeutics funding overview

CHARM Therapeutics is a Biotech company based in Cambridge, MA. CHARM Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for CHARM Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures. 6 distinct backers are named across the disclosed rounds.

CHARM Therapeutics at a glance

Total raised: $80M
Latest round: Series B
Latest round date: September 2025
Industry: Biotech
Headquarters: Cambridge, MA
Notable investors: New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures

Frequently asked about CHARM Therapeutics funding

How much has CHARM Therapeutics raised?: CHARM Therapeutics has raised $80M in total disclosed funding across the rounds on record.
Who has invested in CHARM Therapeutics?: New Enterprise Associates, SR One, OrbiMed, F-Prime, NVIDIA, Khosla Ventures are named among the investors backing CHARM Therapeutics.
What was the latest CHARM Therapeutics funding round?: The most recent disclosed round is a Series B, announced in September 2025.
Where is CHARM Therapeutics based?: CHARM Therapeutics is based in Cambridge, MA.
What sector does CHARM Therapeutics operate in?: CHARM Therapeutics is tracked under Biotech from Cambridge, MA, with $80M in disclosed funding.
When did CHARM Therapeutics last raise?: The last disclosed CHARM Therapeutics round closed in September 2025 at Series B.

CHARM Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.

CHARM Therapeutics Funding: $80M Raised, Series B (2025)

CHARM Therapeutics funding overview

CHARM Therapeutics at a glance

Frequently asked about CHARM Therapeutics funding

CHARM Therapeutics founders (1)

Companies related to CHARM Therapeutics (40)

Browse related funding lists (9)